The Recall Desk
SevereFDA (Drugs)·D-0889-2016·Announced 2016-06-01

African Black Ant capsules recalled for lack of FDA approval

R Thomas Marketing, LLC is recalling African Black Ant capsules because they were marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA).

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The agency classification is FDA Class I, which per the rubric mandates a minimum score of 4 (Severe).

Plain-English summary

R Thomas Marketing, LLC is recalling African Black Ant, a product packaged in 8 small boxes containing 6 capsules each (48 capsules total). The product is distributed by R Thomas Marketing, LLC in Bronx, NY.

The recall is being conducted because the product was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA). This means the product has not been evaluated by the FDA for safety, efficacy, or quality.

The product was distributed nationwide via Internet sales. Consumers who have purchased this product should stop using it and contact the distributor for further instructions.

The recalled product

Product
African Black Ant, packaged in 8 small boxes / 6 capsules per box / 48 capsules total, Distributed by: R Thomas Marketing, LLC, Bronx, NY 10467

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • all lots

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 24 recalled by R Thomas Marketing, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 24 products in this recall →

Same manufacturer · R Thomas Marketing, LLC

See all →